Biosimilars have the potential to change the way we think about, identify, and manage health problems. They are already impacting both clinical research and patient care, and this impact will only grow as our understanding and technologies improve. Written by a team of experienced specialists in clinical development, this book discusses various potential drug development strategies, the design and analysis of pharmacokinetics (PK) studies, and the design and analysis of efficacy studies.
Buy this ebook and get 1 more FREE!
Format EPUB ● Pages 268 ● ISBN 9781315355900 ● Editor Kerry B. (Pfizer, Cambridge, Massachusetts, USA) Barker & Sr., Ralph B. (Boston University, Massachusetts, USA) D’Agostino ● Publisher CRC Press ● Published 2016 ● Downloadable 3 times ● Currency EUR ● ID 5021283 ● Copy protection Adobe DRM
Requires a DRM capable ebook reader